NORIHIRO WATANABE to Breast Neoplasms
This is a "connection" page, showing publications NORIHIRO WATANABE has written about Breast Neoplasms.
Connection Strength
0.142
-
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer. J Immunother Cancer. 2021 11; 9(11).
Score: 0.080
-
CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation. J Immunother Cancer. 2018 05 10; 6(1):34.
Score: 0.063